Clean Science Q1FY27: Profit, dividend, board moves

Key takeaway from the quarter

Clean Science & Technology Ltd reported mixed Q1FY27 numbers, with standalone profitability and revenue declining year-on-year, while consolidated profit and revenue rose. The company said its Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 on August 1, 2026, after a limited review by statutory auditors Price Waterhouse Chartered Accountants LLP. Alongside the results, the Board cleared a final dividend for FY2025-26, made a board-level appointment effective the same day, and sanctioned a new subsidiary in the Netherlands focused on specialty chemical distribution.

Standalone Q1FY27 performance: profit and revenue fell

On a standalone basis, Clean Science posted net profit after tax of ₹73.29 crore in Q1FY27, a 4.3% decline from ₹76.57 crore in Q1FY26. Revenue from operations also fell 5.8% year-on-year to ₹207.10 crore from ₹219.91 crore. Basic earnings per share (EPS) declined to ₹6.90 from ₹7.21, reflecting the lower standalone profit.

The company’s standalone numbers point to a weaker year-on-year quarter at the parent entity level, based on the figures disclosed with the results. The disclosure does not provide a detailed segment-wise or cost-line explanation for the standalone decline within the text provided, but the headline movement is clear across both revenue and profit.

Consolidated Q1FY27 performance: revenue grew 10.5%

At the consolidated level, the same quarter showed growth. Net profit after tax rose 4.7% year-on-year to ₹73.35 crore from ₹70.06 crore in Q1FY26. Consolidated revenue from operations increased 10.5% to ₹268.43 crore from ₹242.87 crore.

Basic EPS on a consolidated basis was reported at ₹6.90 versus ₹6.59 in the corresponding quarter last year. The combination of higher consolidated revenue and higher consolidated profit, contrasted with lower standalone revenue and profit, indicates that the group-level performance benefited from consolidation effects relative to the parent-only view.

Why standalone and consolidated trends diverged

Standalone financials reflect only the performance of Clean Science & Technology Ltd as a parent entity, while consolidated numbers combine the parent and its subsidiaries (after consolidation adjustments). In Q1FY27, that distinction mattered: the standalone profit declined year-on-year, but consolidated profit increased.

The disclosure included announcements about corporate actions such as a new overseas subsidiary and a strategic supply agreement, but it did not specify operational drivers behind the standalone decline or the consolidated improvement in the excerpt provided. Investors typically track both sets of numbers to understand where growth is being generated across the group.

Board approval and audit review

The company said the Board of Directors approved the unaudited standalone and consolidated financial results on August 1, 2026. The results were subject to a limited review by Price Waterhouse Chartered Accountants LLP, the statutory auditors.

This timeline is relevant for shareholders because the same meeting also covered governance and capital-return decisions, including a final dividend and changes to the Board.

Final dividend announced: key dates investors should note

Clean Science declared a final dividend for FY2025-26. As per the company’s disclosure, the dividend is payable on September 30, 2026 to shareholders whose names appear on the register of members as of the record date.

The record date was set as September 5, 2026. Investors typically track the record date closely because eligibility for the dividend depends on shareholding as of that date, subject to settlement timelines.

Board appointment: Additional Director co-opted

The Board co-opted Mr. Krishnakumar Satyanarain Saboo (DIN: 11863005) as an Additional Director with effect from August 1, 2026. The company said he will hold office until the 23rd Annual General Meeting (AGM), scheduled for September 12, 2026.

The Board also recommended his appointment as a Whole-time Director for a five-year term, from August 1, 2026 to July 31, 2031. The AGM date provides a clear next checkpoint for shareholders on the proposed appointment.

Netherlands subsidiary approved for distribution

Clean Science said it sanctioned a new subsidiary in the Netherlands for specialty chemical distribution. While the company did not provide financial guidance or investment numbers in the excerpt provided, the decision signals a formal step to set up an overseas distribution presence.

For specialty chemical companies, distribution footprints can be important in servicing customers in regulated markets, improving delivery timelines, and building local market access. However, the disclosure here was limited to the approval decision itself.

Five-year supply agreement with Kemin Industries

The company also disclosed that it has secured a five-year strategic supply agreement with Kemin Industries. The agreement is to provide key ingredients for the food and feed industry.

The announcement adds a contractual, multi-year element to the company’s business updates in the same period as the quarterly results and board decisions. The excerpt does not include revenue visibility, product details, or volumes linked to this agreement.

Stock move around the result period

The data included multiple price points indicating a mild decline in the stock price in the period referenced. The share price was shown around ₹769.65 (down 1.07%) and ₹767.80 (down 1.44%) in earlier ticks, and “Today” was shown at ₹764.30. Another line cited the current price at ₹764.45, with an open at ₹774.95 and previous close at ₹767.90.

These are point-in-time prints rather than a single end-of-day summary, but they indicate the stock traded lower around the time the updates were circulating.

Key reported numbers at a glance (₹ crore)

All rupee amounts below are converted to ₹ crore for consistency (₹10 million = ₹1 crore).

What to watch next

For shareholders, the next firm dates are the record date for the final dividend (September 5, 2026), the dividend payment date (September 30, 2026), and the 23rd AGM (September 12, 2026), where the Board’s recommendation on the Whole-time Director appointment is expected to be considered.

On the business side, the Netherlands subsidiary approval and the five-year supply agreement with Kemin Industries are notable corporate updates, but the excerpt does not quantify their near-term financial impact. Future filings and quarterly disclosures will be key to tracking how these decisions translate into revenue mix and group-level performance.